BIOXXMED AG INH O.N./ DE000A0KFRJ1 /
26/04/2024 17:36:08 | Var. +0.020 | Volume | Denaro26/04/2024 | Lettera26/04/2024 | Capitalizzazione di mercato | Dividend Y. | Rapporto P/E |
---|---|---|---|---|---|---|---|
0.488EUR | +4.27% | 1,027 Fatturato: 512.366 |
-Quantità in denaro: - | -Quantità in lettera: - | 1.97 mill.EUR | 0.00% | - |
Newsfile Corp
03:20
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Importa...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Che...
GlobeNewswire
03:00
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Ocu...
GlobeNewswire
02:40
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Exscientia plc with Losses to ...
GlobeNewswire
02:17
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Akero Therapeutics, Inc.with L...
Newsfile Corp
01:11
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Checkpoint Therapeutics, Inc. Investors to Se...
Newsfile Corp
28/04
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Befor...